Call us 24/7


Lung Cancer Center, Philadelphia

Your treatment options

Lung Cancer Center

Lung cancer is the leading cause of cancer-related death in the United States and often is diagnosed in advanced stages. The earlier the disease is detected, the more options may be available to treat it. But deciding which option is right for you can be an overwhelming experience. If you have been diagnosed with lung cancer, it is important to turn to a team of experts who are singularly focused on treating lung cancer. New treatment options are rapidly evolving in this era of precision medicine and advanced genomic testing. That’s why putting your trust in a team experienced in these innovations, a team whose expertise comes from working with lung cancer patients every day, may be key to finding a treatment plan that fits your needs and goals.

At the Lung Cancer Center at Cancer Treatment Centers of America® (CTCA) in Philadelphia, our oncologists and clinicians are vigilant in staying up to date on today’s developments in lung cancer diagnostics and treatments. Because they work together daily, all under one roof, their multidisciplinary collaboration is comprehensive and efficient, and they are committed to sharing information that is clear and concise. Our lung cancer experts work as a team to educate you about available treatment options, collaborating with you to help you make informed decisions about your care.

Our Lung Cancer Center doctors

Shayma Master Kazmi - Hematologist-Oncologist & Medical Oncologist

Shayma Master Kazmi

Medical Oncologist & Hematologist, CTCA Philadelphia

Emil Abramian - Director of Interventional Pulmonology & Critical Care Physician

Emil Abramian

Director of Interventional Pulmonology, CTCA Philadelphia

Jeffrey Hoag - Chief of Staff

Jeffrey Hoag

Chair, CTCA Department of Medicine

David P. Visco - Chief, CTCA Division of Hospital Medicine

David P. Visco

Medical Director, Hospitalist Program & Sleep Medicine, CTCA Philadelphia

Jason Lu - Pulmonologist & Critical Care Medicine Physician

Jason Lu

Pulmonologist & Critical Care Medicine Physician, Chief of Medicine, CTCA Philadelphia

Kevin Kasper - Cardiologist

Kevin Kasper

Cardiologist, CTCA Philadelphia

Fernando U. Garcia - Pathologist

Fernando U. Garcia

Pathologist, CTCA Philadelphia

Learn more

U.S. News & World Report names CTCA Philadelphia high-performing hospital for lung cancer surgery

Each year, U.S. New & World Report evaluates the performance of nearly 4,400 hospitals nationwide in lung cancer surgery using data on patient survival, nurse staffing, volume and more. Hospitals receive one of three ratings: high-performing, average or below-average.

For 2020-21, CTCA Philadelphia received the highest possible ranking for lung cancer surgery, named a “high-performing” hospital in this category.

A comprehensive team approach

The doctors at the Lung Cancer Center in Philadelphia are part of a wider multidisciplinary team of cancer experts dedicated to a single mission: providing lung cancer patients with state-of-the-art treatment options that are tailored to their cancer type, stage and quality-of-life needs. Our team is coordinated by a nurse navigator who helps direct patients through their treatment journey. Our pathologists work behind the scenes to diagnose and stage the cancer, conducting specialized testing to help identify the array of treatment options available to each patient.

Depending on your specific needs, your care team may also include a surgical oncologist, radiation oncologist, cardiologist and supportive care clinicians trained in helping cancer patients manage related side effects. The entire team works with a whole-person focus that is at the heart of the center’s dedication to comprehensive, personalized care.

Interventional pulmonology

As part of the Lung Cancer Center at CTCA® Philadelphia, the Interventional Pulmonology Department treats lung cancer and the related symptoms that may cause discomfort, like shortness of breath, coughing or chest pain, all without performing surgery. The team also treats patients with cancers that metastasize to the lungs and patients with other chronic lung diseases.

The interventional pulmonology team at CTCA Philadelphia includes leaders in routine pulmonology, interventional pulmonology, sleep medicine and critical care medicine, such as Dr. Jeffrey Hoag and Dr. David Visco. The members of our interventional pulmonology team use advanced, minimally invasive bronchoscopy techniques and ablative treatments to help remove obstructions in the airways and relieve pain or breathing problems.

Quality of life

Lung cancer patients may experience side effects, including pain, fatigue, appetite loss and neuropathy. To help manage these treatment-related complications, your care team may recommend specific supportive care services, such as pain management, mind-body therapy and spiritual support. Our oncology rehabilitation team is available to help you build strength, reduce pain and manage fatigue, and our smoking cessation program may offer additional tools if you need help transitioning to a tobacco-free lifestyle. Your care team will work together to provide you with options tailored to your individual needs and goals and help support your quality of life throughout treatment.

Learn more about how integrative cancer care may help you manage your lung cancer journey

George Rader

George Alan R.

Lung Cancer

"My medical oncologist, Dr. Aithal, presented everything to me in an honest and forthright manner. She offered hope, but it was never any fluffy false hope, just matter-of-fact, real hope. She proposed the game plan for my treatment. I was to receive 30 radiation treatments (TomoTherapy® five days a week for six weeks) and a whole lot of chemo (a regimen that included cisplatin and etoposide). The plan was to shrink and kill the tumor and then, hopefully, doctors would be able to remove it surgically. It was an aggressive plan of attack, and I liked that."


More About GEORGE

Lung cancer clinical trials

Clinical trials are an essential testing ground for measuring the effectiveness of drugs and other treatments before they can win government approval. Trials may offer lung cancer patients new treatment options that would otherwise be unavailable to them. The CTCA® Lung Cancer Center in Philadelphia is dedicated to offering state-of-the-art and innovative treatment options, including carefully selected clinical trials in targeted therapy, immunotherapy, chemotherapy and other evolving approaches. Our team will help you determine whether you may be a candidate for an available study and, if so, help you enroll. Learn more with our Clinical Trials Q&A. Learn more about our lung cancer clinical trials.

Clinical trials Q&A

Who may benefit from lung cancer clinical trials?

Patients are considered for lung cancer clinical trials on a case-by-case basis. This is a time of rapid scientific advances in lung cancer treatment. New surgical techniques are designed to remove lung tumors while reducing the amount of trauma to healthy tissue. Meanwhile, a new generation of lung cancer therapies is being developed to attack tumors that have specific genomic mutations. These new targeted treatments may have more positive outcomes and cause fewer side effects than traditional chemotherapy. But they are so specialized that only a limited subset of lung cancer patients qualifies for participation. Genomic tumor testing may determine whether you are a candidate for these treatments. Other factors—such as the tumor’s DNA mutations and stage, how you have responded to past treatments and other individual considerations—may also determine whether you qualify for specific trials.

Are they only available to patients who have exhausted other lung cancer treatment options?

Lung cancer patients may qualify to participate in a clinical trial at any stage of their treatment journey. Some patients may join a clinical trial when they first start treatment, in conjunction with standard therapy, on the chance it may offer better results. Other trials are designed for lung cancer patients who have not responded adequately to conventional treatments. Your Lung Cancer Center oncologist will discuss the options and risks, and explain the various protocols involved.

How does CTCA select the trials it offers?

The experts at the Lung Cancer Center in Philadelphia are always searching for innovative ways to treat lung cancer. Offering carefully selected clinical trials when appropriate helps us fulfill that mission. The new generation of precision drugs is generally designed to deliver more targeted, less toxic therapies. Our oncologists decide to participate as a clinical trial site only after careful consideration of the relative benefit to patients.

How do I find out whether a specific clinical trial may benefit me?

Your Lung Cancer Center oncologist and care team may recommend a trial, depending on a number of factors, including your individual needs and treatment goals. Learn more about ongoing lung cancer clinical trials at CTCA. For general questions, contact an Oncology Information Specialist at 888-841-9129.

Where we are located

CTCA Philadelphia

Lung Cancer Center
1331 E. Wyoming Ave.
Philadelphia, PA 19124

New Patients:888-552-6760
Existing Patients:(215) 607-CTCA

Get directions

New research

Offering clinical trials on new and emerging cancer treatment options.

View our clinical trials

What’s your risk?

Take our cancer risk management questionnaire to help assess your risk and take control.

Assess your cancer risk

Insurance plans

We accept a wide range of insurance plans.

Verify your insurance